Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Superficial bladder cancer: progression and recurrence.

N M Heney, S Ahmed, M J Flanagan

    The Journal of Urology
    |December 1, 1983
    PubMed
    Summary

    Bladder cancer progression is significantly higher in stage T1 tumors compared to stage Ta. High-grade tumors and other factors like lamina propria invasion indicate a higher risk of recurrence and shorter disease-free intervals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder.

    British journal of cancer·2004
    Same author

    Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.

    Urology·2002
    Same author

    Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.

    Urology·2001
    Same author

    The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response.

    The oncologist·2000
    Same author

    An isocentrically mounted stand for total body irradiation.

    The British journal of radiology·2000
    Same author

    Endothelial cell E- and P-selectin up-regulation in murine contact sensitivity is prolonged by distinct mechanisms occurring in sequence.

    Journal of immunology (Baltimore, Md. : 1950)·1999

    Area of Science:

    • Urology
    • Oncology
    • Pathology

    Background:

    • Bladder cancer is a common malignancy.
    • Early-stage bladder cancer (Ta and T1) requires careful monitoring for progression and recurrence.
    • Transurethral resection (TUR) is a primary treatment for non-muscle invasive bladder cancer.

    Purpose of the Study:

    • To analyze tumor progression and recurrence rates in patients with initial stages Ta and T1 bladder cancer.
    • To identify factors associated with disease progression and shorter disease-free intervals.

    Main Methods:

    • Retrospective analysis of 249 patients with initial stages Ta and T1 bladder cancer.
    • Data collected on tumor stage, grade, progression, and recurrence.
    • Exclusion of patients receiving intravesical chemotherapy after the first recurrence to focus on progression predictors.

    Related Experiment Videos

    Main Results:

    • Progression rates for stages Ta and T1 were 4% and 30% respectively.
    • Progression rates for grades I, II, and III were 2%, 11%, and 45% respectively.
    • Nontumor dysplasia, tumor size, high tumor grade, lamina propria invasion, atypia, positive urinary cytology, tumor multiplicity, and large tumors were significantly associated with shorter disease-free intervals.

    Conclusions:

    • Stage T1 bladder cancer demonstrates a significantly higher progression rate than stage Ta.
    • High tumor grade is a critical predictor of disease progression.
    • Multiple clinicopathological factors independently predict shorter intervals free of disease, highlighting the need for risk stratification.